Brain Advance Access originally published online on January 9, 2006
Brain 2006 129(3):617-624; doi:10.1093/brain/awh726
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study
Departments of 1 Public Health and 2 Child Neurology, University of Turku, Turku, Finland and 3 Epilepsy Research Group, Berlin, Germany
Correspondence to: Prof. Dr. Dieter Schmidt, Epilepsy Research Group, Goethestrasse 5, D-14163 Berlin, Germany E-mail: dbschmidt{at}t-online.de
It is not well known how often drug resistance, a major clinical problem, occurs early or late in the course of epilepsy and how often epilepsy follows a continuous, remitting or relapsing–remitting pattern. To provide evidence if, in fact, different patterns of evolution of drug resistance and remission exist, a prospective, long-term population-based study of 144 patients followed on the average for 37.0 years (SD 7.1, median 40.0, range 11–42) since their first seizure before the age of 16 years was performed. At the end of follow-up, 67% of 144 patients were in terminal remission, on or off antiepileptic drugs. Early remission, starting within the first year of treatment, was seen in 45 patients (31%). In 23 (16%) of them, first remission continued, uninterrupted by relapse, to terminal remission. Late remission with a mean delay of 9 years was achieved by a further 72 patients (50%), including 46 (32%) patients who achieved terminal remission without any relapse and suggested, together with 23 patients, a remitting course. Following a relapse after early or late remission, 28 (19%) patients achieved terminal remission, suggesting a remitting–relapsing pattern. Altogether 20 patients (14%) did not re-enter remission, indicating a worsening course of epilepsy. Twenty-seven (19%) patients were drug-resistant from the start to the end of follow-up. In conclusion, half the patients with childhood-onset epilepsy will eventually enter terminal remission without relapse and a fifth after relapse. One-third will have a poor long-term outcome in terms of persistent seizures after remission or without any remission ever.
Key Words: pharmacoresistance; drug resistance; antiepileptic drugs; clinical patterns; remission
Abbreviations: AEDs = antiepileptic drugs
Received April 7, 2005. Revised October 11, 2005. Accepted November 25, 2005.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Sillanpaa and D. Schmidt Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy Brain, April 1, 2008; 131(4): 938 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Mathern and E. Trevathan Childhood-onset temporal lobe epilepsy: Neuroimaging predicts seizure control Neurology, December 26, 2006; 67(12): 2117 - 2118. [Full Text] [PDF]
|
|